Data / Drug companies / E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC
E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC: 38 products in the FDA NDC directory, labeler code 0168
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC (labeler code 0168) lists 38 products in the FDA National Drug Code Directory, covering 18 finished drugs by generic name. By type: 37 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on March 9, 2016.
The request: Watch E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC (FDA labeler code 0168): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0168
- Products in commercial distribution
- 38
- Packages
- 67
- Finished drugs by generic name
- 18
- Prescription products
- 37
- Over the counter products
- 1
- Flagged as original packager
- 37 of 37 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 3, 1970
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 30 | 78.9% |
| New drug applications (NDA) | 6 | 15.8% |
| Over the counter monograph drugs | 1 | 2.6% |
| Authorized generics (NDA) | 1 | 2.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 37 | 97.4% |
| Over the counter drugs | 1 | 2.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Betamethasone dipropionate | 5 | 27 |
| Triamcinolone acetonide | 5 | 77 |
| Hydrocortisone | 4 | 171 |
| Clindamycin phosphate | 4 | 31 |
| Betamethasone valerate | 3 | 10 |
| Terconazole | 2 | 6 |
| Metronidazole | 2 | 68 |
| Tacrolimus | 2 | 35 |
| Fluocinolone acetonide | 2 | 17 |
| Adapalene | 1 | 34 |
| Ketoconazole | 1 | 35 |
| Swim-ear | 1 | 1 |
| Lidocaine | 1 | 216 |
| Lidocaine and prilocaine | 1 | 14 |
| Fluocinonide | 1 | 25 |
| Oxiconazole nitrate | 1 | 3 |
| Clotrimazole and betamethasone dipropionate | 1 | 15 |
| Clobetasol propionate | 1 | 40 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 16 | 42.1% |
| Ointment | 10 | 26.3% |
| Solution | 5 | 13.2% |
| Lotion | 4 | 10.5% |
| Ointment, augmented | 1 | 2.6% |
| Lotion, augmented | 1 | 2.6% |
| Gel | 1 | 2.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Corticosteroid | 22 |
| Azole Antifungal | 5 |
| Lincosamide Antibacterial | 4 |
| Amide Local Anesthetic | 2 |
| Antiarrhythmic | 2 |
| Nitroimidazole Antimicrobial | 2 |
| Calcineurin Inhibitor Immunosuppressant | 2 |
| Retinoid | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Oxiconazole Nitrate | 0168-0358 | Cream | Authorized generics (NDA) | March 9, 2016 |
| Tacrolimus | 0168-0417 | Ointment | Generic drugs (ANDA) | September 9, 2014 |
| Tacrolimus | 0168-0416 | Ointment | Generic drugs (ANDA) | September 9, 2014 |
| Adapalene | 0168-0424 | Cream | Generic drugs (ANDA) | June 30, 2010 |
| Betamethasone Dipropionate | 0168-0267 | Lotion, augmented | Generic drugs (ANDA) | May 21, 2007 |
| Metronidazole | 0168-0383 | Lotion | Generic drugs (ANDA) | May 24, 2006 |
| Terconazole | 0168-0346 | Cream | Generic drugs (ANDA) | February 18, 2005 |
| Terconazole Vaginal Cream 0.8% | 0168-0347 | Cream | New drug applications (NDA) | February 1, 2005 |
| Clindamycin Phosphate | 0168-0277 | Cream | Generic drugs (ANDA) | December 27, 2004 |
| Metronidazole | 0168-0323 | Cream | Generic drugs (ANDA) | May 28, 2004 |
| Ketoconazole | 0168-0099 | Cream | Generic drugs (ANDA) | April 28, 2004 |
| Lidocaine and Prilocaine | 0168-0357 | Cream | Generic drugs (ANDA) | August 18, 2003 |
| Clindamycin phosphate | 0168-0203 | Lotion | Generic drugs (ANDA) | January 31, 2002 |
| Clotrimazole and Betamethasone Dipropionate | 0168-0258 | Cream | Generic drugs (ANDA) | June 5, 2001 |
| Clindamycin phosphate | 0168-0202 | Gel | Generic drugs (ANDA) | January 28, 2000 |
| Betamethasone Dipropionate | 0168-0268 | Ointment, augmented | Generic drugs (ANDA) | June 22, 1999 |
| Clobetasol Propionate | 0168-0269 | Solution | Generic drugs (ANDA) | February 8, 1999 |
| Clindamycin phosphate | 0168-0201 | Solution | Generic drugs (ANDA) | June 5, 1997 |
| Fluocinonide | 0168-0134 | Solution | Generic drugs (ANDA) | February 27, 1995 |
| Hydrocortisone | 0168-0146 | Ointment | Generic drugs (ANDA) | May 28, 1993 |
| Hydrocortisone | 0168-0080 | Cream | Generic drugs (ANDA) | December 16, 1986 |
| Betamethasone Dipropionate | 0168-0057 | Lotion | Generic drugs (ANDA) | August 12, 1985 |
| Betamethasone Dipropionate | 0168-0056 | Ointment | New drug applications (NDA) | September 4, 1984 |
| Betamethasone Dipropionate | 0168-0055 | Cream | New drug applications (NDA) | June 26, 1984 |
| Betamethasone Valerate | 0168-0041 | Lotion | New drug applications (NDA) | August 31, 1983 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.